Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human GCH1 ELISA Kit (AC2881)
Cat.#: ASET-1470
Specifications
Description Human GCH1 ELISA Kit allows for the in vitro quantitative determination of human GCH1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2162 Rat AANAT ELISA Kit (AC3573) Quantitative inquiry ASET-1569 Rat alpha MSH ELISA Kit (AC2980) Quantitative inquiry ASET-2042 Human Ephrin A4 ELISA Kit (AC3453) Quantitative inquiry ASET-1438 Human COLEC12 ELISA Kit (AC2849) Quantitative inquiry ASET-1597 Human Laminin ELISA Kit (AC3008) Quantitative inquiry ASET-2056 Bovine Insulin ELISA Kit (AC3467) Quantitative inquiry ASET-1413 Rat Ferritin Heavy Chain ELISA Kit (AC2824) Quantitative inquiry ASET-1338 Human FOXO1A ELISA Kit (AC2749) Quantitative inquiry ASET-1739 Human Repulsive Guidance Molecule A ELISA Kit (AC3150) Quantitative inquiry ASET-2316 Rat IL-6 ELISA Kit (AC3727) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket